British Bio-technology Group PLC will be included in theFinancial Times' 500 share index as of this month, the LondonStock Exchange announced Friday. The emerging pharmaceuticalcompany is based in Oxford, England, and has a marketvaluation of $300 million.

(c) 1997 American Health Consultants. All rights reserved.

No Comments